Novartis Oncology, Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Novartis Oncology, Inc.
... Alessandro will also join Gilead's Executive Committee. Dr. Riva joins Gilead from Novartis Oncology, where he served as Head, Global Oncology Development. He was responsible ...
... demonstrate our continued commitment to the CML community Basel, December 5, 2016- Novartis today announced at the 58th American Society of Hematology (ASH) Annual Meeting ...
... vera or essential thrombocythemia, was presented at ASH[1] Basel, December 5, 2016- Novartis today announced results from the first-ever international survey of patients with myeloproliferative ...
... placebo (1.63 vs 2.98, p=0.010) in patients with or without hydroxyurea therapy[1]. Novartis today announced that the data are being featured in the official press ...
Want to see the full history on Novartis Oncology, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial